ArticleFrontiers in pharmacology2022

Combination of the parent analogue of remdesivir (GS-441524) and molnupiravir results in a markedly potent antiviral effect in SARS-CoV-2 infected Syrian hamsters.

Rana Abdelnabi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.